Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 301 followers
Latest posts
Last updated about 10 hours ago
Edwards highlights 8-year durability data for its Resilia-equipped heart valves
about 10 hours ago
As it aims to broaden the reach of its replacement heart valves...
Alis offers exit option to biotechs tainted by tang of failure, providing way to return cash to shareholders
about 12 hours ago
Alis Biosciences has made a pitch to the hundreds of biotechs that...
NIH nixes support for Pluri’s radiation exposure cell therapy amid cost-cutting drive
about 13 hours ago
The U.S. government has pulled the rug out from under Pluri Biotech’s...
Chutes & Ladders—AIRNA appoints Elevidys architect as CMO
about 14 hours ago
Just a few weeks after closing a $155 million series B, RNA...
‘America-first resurgence’: Amid market correction, biotech nears new era, PitchBook says
about 14 hours ago
Biotechs will need to be strategic to achieve “tariff-era success” as the...
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
about 15 hours ago
VelaVigo Bio has landed its second deal in six months, offloading ex-China...
'An unwinnable situation': FDA delays force one biopharma to shelve phase 3 plans, WSJ reports
1 day ago
After mass layoffs, the FDA has started missing certain deadlines, pushing one...
Liver-targeting vaccine protects mice from allergic asthma reactions for at least a year
1 day ago
An “inverse vaccine” that delivers deactivated allergens to the liver was able...
FDA clears its first prescription migraine app, from Click Therapeutics
1 day ago
Designed to be used alongside standard medications, a randomized trial of Click’s...
FDA clears Precision Neuroscience’s minimally invasive brain-computer interface implant
1 day ago
The company described it as the first regulatory green light for a...
Elevation is latest biotech to face activist investor demands to wind down
1 day ago
Elevation Oncology has become the second biotech this week to face calls...
Evotec axes 30% of assets as cost-cutting push hits pipeline
1 day ago
Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30%...